The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …

Objective The aim was to review and analyse the literature on clinical outcomes of drug
coated balloon (DCB) vs. standard percutaneous transluminal angioplasty (PTA) for the …

Introduction Chronic limb threat ischemia is associated with cardiovascular events, resulting
in high amputation, morbidity and mortality rates. This study aims to accomplish a …

Objectives The goal of this study was to evaluate the 5-year follow-up data of the IN. PACT
DEEP (Randomized IN. PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard …

Purpose: To investigate the safety and efficacy of drug-coated balloons (DCB) for the
treatment of femoropopliteal or infrapopliteal lesions in patients with chronic limb …

Objective Historically, open surgical bypass provided a durable repair among diabetic
patients with chronic limb-threatening ischemia (CLTI). In the current endovascular era …

Background To investigate whether lower limb vascular intervention or autologous platelet-
rich gel (APG) treatment would benefit diabetic lower extremity arterial disease (LEAD) …

Background Luminor is a new drug-coated angioplasty balloon, which is approved by the
European Conformity market. The aim of the present study is to analyze the 1-year results, in …

Despite a lack of solid evidence in applying the angiosome concept (AC) in current chronic
limb threatening ischemia (CLTI) treatment, several encouraging results for improved wound …

Introducción: La macroangiopatía diabética constituye un serio problema para los pacientes
que la portan y la cirugía revascularizadora constituye una alternativa de tratamiento …